View Item 

Show simple item record

Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea
dc.contributor.authorChen, Fu-Quanen_US
dc.contributor.authorSchacht, Jochenen_US
dc.contributor.authorSha, Su-Huaen_US
dc.date.accessioned2010-04-01T15:47:29Z
dc.date.available2010-04-01T15:47:29Z
dc.date.issued2009-03en_US
dc.identifier.citationChen, Fu-Quan; Schacht, Jochen; Sha, Su-Hua (2009). "Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea." Journal of Neurochemistry 108(5): 1226-1236. <http://hdl.handle.net/2027.42/66284>en_US
dc.identifier.issn0022-3042en_US
dc.identifier.issn1471-4159en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/66284
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19141081&dopt=citationen_US
dc.format.extent1650648 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsJournal compilation © 2009 International Society for Neurochemistryen_US
dc.subject.otherCochlear Explanten_US
dc.subject.otherGentamicinen_US
dc.subject.otherHistone Acetyl Transferaseen_US
dc.subject.otherHistone Deacetylase Inhibitorsen_US
dc.subject.otherOtotoxicityen_US
dc.titleAminoglycoside-induced histone deacetylation and hair cell death in the mouse cochleaen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid19141081en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/66284/1/j.1471-4159.2009.05871.x.pdf
dc.identifier.doi10.1111/j.1471-4159.2009.05871.xen_US
dc.identifier.sourceJournal of Neurochemistryen_US
dc.identifier.citedreferenceBhaumik S. R., Smith E. and Shilatifard A. ( 2007 ) Covalent modifications of histones during development and disease pathogenesis. Nat. Struct. Mol. Biol. 14, 1008 – 1016.en_US
dc.identifier.citedreferenceDashwood R. H. and Ho E. ( 2007 ) Dietary histone deacetylase inhibitors: from cells to mice to man. Semin. Cancer Biol. 17, 363 – 369.en_US
dc.identifier.citedreferenceDing D., Stracher A. and Salvi R. J. ( 2002 ) Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hear. Res. 164, 115 – 126.en_US
dc.identifier.citedreferenceDrottar M., Liberman M. C., Ratan R. R. and Roberson D. W. ( 2006 ) The histone deacetylase inhibitor sodium butyrate protects against cisplatin-induced hearing loss in guinea pigs. Laryngoscope 116, 292 – 296.en_US
dc.identifier.citedreferenceElaut G., Laus G., Alexandre E., Richert L., Bachellier P., Tourwe D., Rogiers V. and Vanhaecke T. ( 2007 ) A metabolic screening study of trichostatin A (TSA) and TSA-like histone deacetylase inhibitors in rat and human primary hepatocyte cultures. J. Pharmacol. Exp. Ther. 321, 400 – 408.en_US
dc.identifier.citedreferenceFischer A., Sananbenesi F., Wang X., Dobbin M. and Tsai L. H. ( 2007 ) Recovery of learning and memory is associated with chromatin remodelling. Nature 447, 178 – 182.en_US
dc.identifier.citedreferenceForge A. and Schacht J. ( 2000 ) Aminoglycoside antibiotics. Audiol. Neurootol. 5, 3 – 22.en_US
dc.identifier.citedreferenceGao L., Cueto M. A., Asselbergs F. and Atadja P. ( 2002 ) Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J. Biol. Chem. 277, 25748 – 25755.en_US
dc.identifier.citedreferenceGlaser K. B. ( 2007 ) HDAC inhibitors: clinical update and mechanism-based potential. Biochem. Pharmacol. 74, 659 – 671.en_US
dc.identifier.citedreferenceHainrichson M., Nudelman I. and Baasvo T. ( 2008 ) Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases. Org. Biomol. Chem. 21, 227 – 239.en_US
dc.identifier.citedreferenceHermann C. ( 2007 ) Review: variability of host-pathogen interaction. J. Endotoxin Res. 13, 199 – 218.en_US
dc.identifier.citedreferenceJiang H., Sha S.-H. and Schacht J. ( 2005 ) The NF-κB pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity. J. Neurosci. Res. 79, 644 – 651.en_US
dc.identifier.citedreferenceJiang H., Sha S. H. and Schacht J. ( 2006a ) Kanamycin alters cytoplasmic and nuclear phosphoinositide signaling in the organ of Corti in vivo. J. Neurochem. 99, 269 – 276.en_US
dc.identifier.citedreferenceJiang H., Sha S. H., Forge A. and Schacht J. ( 2006b ) Caspase-independent pathways of hair cell death induced by kanamycin in vivo. Cell Death Differ. 13, 20 – 30.en_US
dc.identifier.citedreferenceKawaguchi Y., Kovacs J. J., McLaurin A., Vance J. M., Ito A. and Yao T. P. ( 2003 ) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115, 727 – 738.en_US
dc.identifier.citedreferenceKim H. J., Rowe M., Ren M., Hong J. S., Chen P. S. and Chuang D. M. ( 2007 ) Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J. Pharmacol. Exp. Ther. 321, 892 – 901.en_US
dc.identifier.citedreferenceLu Q., Qiu X., Hu N., Wen H., Su Y. and Richardson B. C. ( 2006 ) Epigenetics, disease, and therapeutic interventions. Ageing Res. Rev. 5, 449 – 467.en_US
dc.identifier.citedreferenceMarks P. A., Richon V. M., Breslow R. and Rifkind R. A. ( 2001 ) Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol. 13, 477 – 483.en_US
dc.identifier.citedreferenceMarks P. A., Richon V. M., Miller T. and Kelly W. K. ( 2004 ) Histone deacetylase inhibitors. Adv. Cancer Res. 91, 137 – 168.en_US
dc.identifier.citedreferenceMorrison B. E., Majdzadeh N., Zhang X., Lyles A., Bassel-Duby R., Olson E. N. and D’Mello S. R. ( 2006 ) Neuroprotection by histone deacetylase-related protein. Mol. Cell. Biol. 26, 3550 – 3564.en_US
dc.identifier.citedreferenceMyrdal S. E., Johnson K. C. and Steyger P. S. ( 2005 ) Cytoplasmic and intra-nuclear binding of gentamicin does not require endocytosis. Hear. Res. 204, 156 – 169.en_US
dc.identifier.citedreferencede Ruijter A. J., van Gennip A. H., Caron H. N., Kemp S. and van Kuilenburg A. B. ( 2003 ) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737 – 749.en_US
dc.identifier.citedreferenceSadri-Vakili G. and Cha J. H. ( 2006 ) Mechanisms of disease: histone modifications in Huntington’s disease. Nat. Clin. Pract. Neurol. 2, 330 – 338.en_US
dc.identifier.citedreferenceSaha R. N. and Pahan K. ( 2006 ) HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ. 13, 539 – 550.en_US
dc.identifier.citedreferenceSha S.-H. and Schacht J. ( 1998 ) Are aminoglycoside antibiotics excitotoxic? Neuroreport 9, 3893 – 3895.en_US
dc.identifier.citedreferenceSha S.-H., Taylor R., Forge A. and Schacht J. ( 2001 ) Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear. Res. 155, 1 – 8.en_US
dc.identifier.citedreferenceSiavoshian S., Segain J. P., Kornprobst M., Bonnet C., Cherbut C., Galmiche J. P. and Blottiere H. M. ( 2000 ) Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 46, 507 – 514.en_US
dc.identifier.citedreferenceTabuchi K., Pak K., Chavez E. and Ryan A. F. ( 2007 ) Role of inhibitor of apoptosis protein in gentamicin-induced cochlear hair cell damage. Neuroscience 149, 213 – 222.en_US
dc.identifier.citedreferenceTaylor J. P. and Fischbeck K. H. ( 2002 ) Altered acetylation in polyglutamine disease: an opportunity for therapeutic intervention? Trends Mol. Med. 8, 195 – 197.en_US
dc.identifier.citedreferenceWu W. J., Sha S. H., McLaren J. D., Kawamoto K., Raphael Y. and Schacht J. ( 2001 ) Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Hear. Res. 158, 165 – 178.en_US
dc.identifier.citedreferenceXu W. S., Parmigiani R. B. and Marks P. A. ( 2007 ) Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26, 5541 – 5552.en_US
dc.identifier.citedreferenceZhang M., Liu W., Ding D. and Salvi R. ( 2003 ) Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis. Neuroscience 120, 191 – 205.en_US
dc.identifier.citedreferenceZheng J. L. and Gao L. ( 1996 ) Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur. J. Neurosci. 8, 1897 – 1905.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1471-4159.2009.05871.x.pdf
Size:
1.574MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.